Milestone Pharmaceuticals Inc.
MIST
$1.07
-$0.06-4.89%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 292.95% | 229.20% | 52.03% | 8.07% | -47.85% |
| Total Receivables | 196.70% | 236.31% | 104.31% | -27.13% | -33.65% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 38.37% | -48.64% | -1.90% | 2.14% | -56.33% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -1.64% | 75.33% |
| Total Current Assets | 290.59% | 217.90% | 51.40% | 7.01% | -47.15% |
|
|
|||||
| Total Current Assets | 290.59% | 217.90% | 51.40% | 7.01% | -47.15% |
| Net Property, Plant & Equipment | 3.92% | 5.04% | 4.26% | -37.06% | -33.32% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 283.04% | 213.05% | 50.41% | 6.10% | -46.86% |
|
|
|||||
| Total Accounts Payable | 188.73% | 320.43% | 192.18% | 95.16% | 290.92% |
| Total Accrued Expenses | 79.49% | -21.64% | 12.79% | 125.22% | 79.64% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 30.10% | 21.59% | 13.31% | -17.01% | -9.17% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 138.97% | 61.57% | 72.03% | 100.15% | 103.26% |
|
|
|||||
| Total Current Liabilities | 138.97% | 61.57% | 72.03% | 100.15% | 103.26% |
| Long-Term Debt | 155.20% | 151.08% | 7.20% | 7.19% | 7.19% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -70.05% | -51.72% | -38.33% | -48.20% | -44.55% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 150.77% | 131.86% | 15.14% | 14.58% | 13.81% |
|
|
|||||
| Common Stock & APIC | 35.53% | 32.80% | 27.20% | 15.92% | 1.79% |
| Retained Earnings | -20.94% | -17.61% | -17.16% | -16.33% | -16.06% |
| Treasury Stock & Other | 4.85% | 4.85% | 4.85% | 4.85% | 0.00% |
| Total Common Equity | 202.67% | 688.75% | 217.71% | -14.62% | -155.49% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 202.67% | 688.75% | 217.71% | -14.62% | -155.49% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 202.67% | 688.75% | 217.71% | -14.62% | -155.49% |
|
|
|||||